Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
Frank Nawroth,1 Andreas Tandler-Schneider,2 Wilma Bilger3 1Centre for Reproductive and Prenatal Medicine, Endocrinology and Osteology, Hamburg, Germany; 2Center for Reproductive Medicine, Fertility Center Berlin, Berlin, Germany; 3Medical Affairs, Fertility, Endocrinology and General Medicine, Merck...
Main Authors: | Nawroth F, Tandler-Schneider A, Bilger W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-04-01
|
Series: | Drug, Healthcare and Patient Safety |
Online Access: | http://www.dovepress.com/multicenter-noninterventional-post-marketing-surveillance-study-to-eva-peer-reviewed-article-DHPS |
Similar Items
-
Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
by: Welcker J, et al.
Published: (2010-09-01) -
Aktuelles: Neuer Follitropin-alfa-Pen getestet
Published: (2011-01-01) -
Aktuelles: Neuer Follitropin-alfa-Pen getestet
Published: (2011-01-01) -
A redesigned follitropin alfa pen injector for infertility: results of a market research study
by: Abbotts C, et al.
Published: (2011-06-01) -
Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
by: Illingworth PJ, et al.
Published: (2014-06-01)